Penumbra, Inc.
NYSE:PENMedical - Devices
-$2.30 today
- Market cap
- $12.64B
- Beta
- 0.70
- P/E (TTM)
- 72.6
- EPS (TTM)
- $4.36
Volume 0.21M
Average 0.50M
PEN Other Working Capital
Cash effect of changes in other operating assets and liabilities.
Penumbra, Inc.NYSE: PEN
Other Working Capital · Q2 FY2026 · quarter ended Jun 2026
Other working capital dips below year-ago levels
Q2 FY2026 other working capital of $3.71M fell 27.6% year over year, behind the +511.8% change in trailing-twelve-month other working capital. Sequentially, it fell 87.6% from the prior quarter. Over 3 fiscal years it compounded at -71.9% a year.
Context
- Other working capital amounted to 0.0% of revenue in FY2025, down 0.9 pp from a year earlier.
- Other working capital increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -27.6% toward the trailing-twelve-month pace of +511.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Working Capital history
USD · from the cash flow
- Latest · FY2025
- 213K USD
- Year-over-year change
- -98.1%
- 4-year CAGR
- -59.3%
| Period | Period end | Other Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 213K | -98.1% |
| FY2024 | 2024-12-31 | 11.11M | +191.0% |
| FY2023 | 2023-12-31 | (12.21M) | -227.6% |
| FY2022 | 2022-12-31 | 9.57M | +23.4% |
| FY2021 | 2021-12-31 | 7.75M | — |
Other Working Capital vs competitors
How PEN compares with its peers on the latest reported figures
- PEN's LTM Jun 2026 other working capital of $28.31M is the 6th largest of the 9 companies compared; the peer median is $3.82M.
- Its year-over-year change of +511.8% is the 2nd highest of 9, against a peer median of +46.8%.
- Other working capital amounts to 1.9% of revenue for PEN, versus a peer median of 1.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.34B | +114.6% | +41.6% | 2.9% | |
| LTM Jul 2026 | $519M | -144.8% | +80.1% | 1.4% | |
| LTM Sep 2026 | $398.5M | -54.8% | -18.9% | 3.4% | |
| LTM Jun 2026 | $104.8M | -21.0% | +37.8% | 1.6% | |
| LTM Jun 2026 | $67M | -73.2% | -25.9% | 0.3% | |
| LTM Jun 2026 | $28.31M | +511.8% | -71.9% | 1.9% | |
| LTM Sep 2026 | $12.34M | +718.0% | -89.3% | 0.8% | |
| LTM Feb 2026 | $6.18M | +145.8% | — | 2.0% | |
| LTM Mar 2026 | $1.46M | +180.1% | — | 0.6% | |
| Peer median (excluding PEN) | $3.82M | +46.8% | +9.4% | 1.5% | |
Competitors are the stored peer set for PEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 5.28M | (2M) | 90.95M | 14.01M | 177.69M |
| Depreciation & Amortization | 16.41M | 24.32M | 27.26M | 23.7M | 17.47M |
| Deferred Income Tax | (14.09M) | 1.46M | (19.06M) | (16.34M) | 21.03M |
| Stock-Based Compensation | 0 | 0 | 0 | 46.16M | 59.21M |
| Change in Working Capital | (66.71M) | (121.54M) | (79.08M) | (23.78M) | (42.72M) |
| Accounts Receivables | (21.34M) | (69.86M) | (266K) | 26.6M | (19.51M) |
| Inventory | (51.55M) | (74.63M) | (67.71M) | (65.66M) | (26.48M) |
| Accounts Payables | (1.57M) | 13.39M | 1.1M | 4.17M | 3.07M |
| Other Working Capital | 7.75M | 9.57M | (12.21M) | 11.11M | 213K |
| Other Non-Cash Items | 68.61M | 42.1M | 77.27M | 124.72M | 5.97M |
| Operating Cash Flow | 9.5M | (55.66M) | 97.33M | 168.48M | 238.66M |
| Capital Expenditures | (21.18M) | (19.3M) | (15.21M) | (21.18M) | (63.73M) |
| Acquisitions (Net) | 2.92M | 0 | (988K) | 0 | 0 |
| Purchases of Investments | (126.79M) | 0 | (81.94M) | (32.91M) | (355.74M) |
| Sales of Investments | 123.72M | 74.09M | 82.57M | 130.62M | 14.88M |
| Other Investing Activities | (400K) | 0 | (500K) | 1.1M | 0 |
| Investing Cash Flow | (21.74M) | 54.79M | (16.08M) | 77.62M | (404.59M) |
| Debt Repayment | (1.45M) | (1.75M) | (1.98M) | (2.28M) | (2.49M) |
| Common Stock Issued | 18.37M | 21.55M | 20.41M | 17.17M | 31.82M |
| Common Stock Repurchased | 0 | 0 | 0 | (100.39M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (16.08M) | (8.18M) | (2.23M) | (1.52M) | (2.8M) |
| Financing Cash Flow | 836K | 11.62M | 16.2M | (87.01M) | 26.53M |
| Effect of Forex Changes | 1.11M | (272K) | 168K | (2.18M) | 1.89M |
| Net Change in Cash | (10.29M) | 10.48M | 97.63M | 156.92M | (137.51M) |
| Free Cash Flow | (11.68M) | (74.96M) | 82.12M | 147.3M | 174.93M |
Penumbra, Inc.
NYSE:PEN
Intrinsic Alpha fair value
Locked
Current Price
$320.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.